Citurgia Biochemicals Reports Zero Revenue and Rs 8.20 Lakh Net Loss for Q1 FY27
Citurgia Biochemicals continues to report zero operational revenue for the quarter ended June 30, 2026, maintaining a trend of operational dormancy. The company recorded a net loss of Rs 8.20 lakhs, which is a marginal improvement from the Rs 8.39 lakh loss in the same quarter last year and a significant reduction from the Rs 25.82 lakh loss in the preceding quarter. Expenses were primarily driven by depreciation (Rs 5.15 lakhs) and employee benefits (Rs 3.00 lakhs). With a negative net worth of Rs 8 crore and zero TTM revenue, the company's financial position remains extremely weak.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company released its unaudited financial results for Q1 FY27, confirming a continued lack of business activity and ongoing net losses.
ஏன் இது முக்கியம்The company is effectively dormant with no revenue and eroding capital; the negative net worth of Rs 8 crore indicates significant insolvency risk.
Total Revenue: Rs 0.00Net Loss: Rs 8.20 LakhsEmployee Benefit Expenses: Rs 3.00 LakhsNet Worth: Rs -8 CrPromoter Holding: 99.36%
📅 குறுகிய காலம்The stock is likely to remain stagnant or under pressure given the lack of operational progress and continued losses.
📈 நீண்ட காலம்The long-term outlook is highly uncertain and limited unless there is a major restructuring or new business injection, given the negative net worth and zero revenue.
⚠ அபாய எச்சரிக்கைகள்
- Zero operational revenue
- Negative net worth of Rs 8 crore
- High promoter concentration (99.36%) limiting public float
- Persistent quarterly losses
👀 கவனிக்க வேண்டியவை
Investors should monitor for any regulatory updates or management announcements regarding the revival of business operations, as the company currently generates no revenue and has a negative net worth.
